US FDA approves Johnson & Johnson's blood cancer therapy | Business Information & News | Westlaw

US FDA approves Johnson & Johnson's blood cancer therapy | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, US FDA approves Johnson & Johnson's blood cancer therapy, Business Information & News
8/10/23 REUTERS 10:49:10
REUTERS
Copyright (c) 2023 Thomson Reuters
August 10, 2023
US FDA approves Johnson & Johnson's blood cancer therapy
Mariam Sunny
Mariam Sunny; Bengaluru
Krishna Chandra Eluri
Maju Samuel
(Reuters) -Johnson & Johnson said on Thursday the U.S. Food and Drug Administration had approved its antibody-based therapy for patients with a difficult-to-treat type of blood cancer.
The therapy, Talvey, belongs to a class of treatments called...
---- Index References ----
Company: U.S. Food and Drug Administration; THE MULTIPLE MYELOMA RESEARCH FOUNDATION, INC.; JOHNSON & JOHNSON
News Subject: (Health & Family (1HE30))
Industry: (Blood Cancer (1BL02); Drug Approval Process (1DR91); Drug Discovery & Development Process (1DR41); Healthcare (1HE06); Healthcare Practice Specialties (1HE49); Internal Medicine (1IN54); Oncology & Hematology (1ON95); Pharmaceuticals (1PH33); Pharmaceuticals & Biotechnology (1PH13); Pharmaceuticals Research & Development (1PH57))
Language: EN
Other Indexing: (US FDA; U.S. Food and Drug Administration; Multiple Myeloma Research Foundation; Johnson & Johnson)
Keywords: health
Word Count: 318
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.